Global Pharmaceutical Drug Delivery Market Report 2022


Key players in the pharmaceutical drug delivery market are 3M Company, Bayer AG, Becton Dickinson And Company, F. Hoffmann-La Roche AG, GlaxoSmithKline Plc, Johnson & Johnson Inc., Merck & Co Inc, Novartis AG, Pfizer Inc, Sanofi S.

New York, Sept. 14, 2022 (GLOBE NEWSWIRE) — Announces Publication of “Pharmaceutical Drug Delivery Global Market Report 2022” –
A., AbbVie Inc., Amgen Inc., AstraZeneca plc., Boehringer Ingelheim, Boston Scientific Corporation, Bristol-Myers Squibb, Consort Medical plc, Eli Lilly and Company, Emergent Biosolutions Inc, Kite Pharma, Nemera France SAS, Nimbus Therapeutics, SHL Medical AG., Teva Pharmaceuticals Industries Ltd. and West Pharmaceutical Services Inc.

The global pharmaceutical drug delivery market is expected to grow from USD 1510.17 billion in 2021 to USD 1591.81 billion in 2022 at a compound annual growth rate (CAGR) of 5.4%. The pharmaceutical drug delivery market is expected to reach $1920.96 billion in 2026 at a CAGR of 4.8%.

The pharmaceutical drug delivery market is the sale of pharmaceutical drug delivery technologies by entities (organizations, sole proprietors, partnerships) used to deliver a pharmaceutical drug to a specific part of the body to treat different diseases. Pharmaceutical drug delivery refers to the process of administering a pharmaceutical compound to achieve a therapeutic effect in humans or animals.

The main types of pharmaceutical drug delivery routes are oral, ocular, pulmonary, nasal, injectable, topical and others. The oral route refers to the administration of a drug through the mouth, which is the most common route of administration. due to its sustained and controlled delivery, ease of administration and feasibility for solid dosage forms.

The various pharmaceutical drug delivery applications include infectious diseases, cancer, cardiovascular diseases, diabetes, respiratory diseases, central nervous system disorders, autoimmune diseases and other applications. The various end users include hospitals, home care facilities, CHWs/clinics, and other end users.

North America was the largest region in the pharmaceutical drug delivery market in 2021. North America is expected to be the fastest growing region during the forecast period.

Regions covered in this Pharmaceutical Drug Delivery market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle- East and Africa.

The Pharmaceutical Drug Dispensing Market research report is one of a series of new reports that provide statistics on the Pharmaceutical Drug Dispensing market, including the global market size of the Dispensing industry Pharmaceutical Drug Delivery, Regional Shares, Competitors Holding Pharmaceutical Drug Delivery Market Share, Detailed segments of the Pharmaceutical Drug Delivery Market. , market trends and opportunities, and any other data you may need to thrive in the Pharmaceutical Drug Delivery industry. This Pharmaceutical Drug Delivery Market research report provides a comprehensive perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The growing prevalence of chronic diseases is expected to propel the growth of the pharmaceutical drug delivery market in the future. Chronic disease prevalence refers to the total number of existing cases of chronic disease in a population at a specific time.

Pharmaceutical drug delivery helps patients with chronic diseases by delivering a pharmaceutical drug to a specific part of the body to treat different diseases. For example, according to the World Health Organization, a specialized agency of the United Nations based in Switzerland, non-communicable diseases kill 41 million people each year, which is equivalent to 71% of all deaths in the world and diseases cardiovascular diseases are responsible for most deaths.

Hence, the growing prevalence of chronic diseases is driving the pharmaceutical drug delivery market.

The adoption of nano drug delivery systems is a key trend that is gaining popularity in the pharmaceutical drug delivery market. The use of nanomaterials in pharmaceutical drug delivery can increase the cellular uptake of drugs due to surface charge and time and they can increase the stability and water solubility of drugs.

For example, in March 2020, Bioavanta-Boston, a Swiss-based chitosan nanoparticle research organization, released Novochizol, a unique polysaccharide nanotechnology that can be used to encapsulate any effective pharmaceutical additive such as a small molecule or a biological product for localized delivery and regular discharge into any organ or tissue, allowing the treatment of severe COVID-19 infection in the lungs.

In May 2022, Halozyme Therapeutics, a US-based biotechnology company, acquired Antares Pharma for $960 million. With this acquisition, Halozyme aims to strengthen its leading position in the distribution of drugs by including Antares specialty products.

Antares Pharma is an American company specialized in the distribution of pharmaceutical drugs.

The countries covered in the Pharmaceutical Drug Delivery market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea South, the United Kingdom and the United States.
Read the full report:

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need – instantly, in one place.


CONTACT: Clare: [email protected] US: (339)-368-6001 Intl: +1 339-368-6001